CompletedNot Applicable

Valsalva Manoeuvre and Intravenous Dexmedetomidine on Attenuating Pain During Propofol Injection in Upper GIT Endoscopy

Saudi Arabia120 participantsStarted 2022-02-19

Plain-language summary

No previous study has cited the use of the Valsalva manoeuvre for the reduction of pain on propofol injection in comparison with dexmedetomidine injection. Therefore, investigators plan a study to evaluate the analgesic efficacy of the Valsalva manoeuvre in alleviating pain during propofol injection as compared to dexmedetomidine injection.

Who can participate

Age range30 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult patients aged 30-60 years old.
✓. American Society of Anesthesiologist physical status(ASA) Grade I and II.
✓. Upper gastrointestinal Endoscopies.

Exclusion criteria

✕. Patients with mental illness, restlessness.
✕. Cardio-respiratory disease.
✕. Chronic pain disorder.
✕. Use of preoperative analgesic medication.
✕. History of propofol allergy.
✕. History of drug abuse.
✕. Inability to perform the Valsalva manoeuvre. -

What they're measuring

Pain Assessment

Timeframe: 20 seconds after propofol injection.

Trial details

NCT IDNCT05225610

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-04-15

View on ClinicalTrials.gov More Injection Site Irritation trials